Table 2.

Pathogenic or likely pathogenic variants of the patients with congenital hyperinsulinism.

GeneTranscriptAlleleProteinIn silico analysesCarriers (n)Ref.
ABCC8NM_000352.4c.560T>Ap.(Val187Asp)P24(9)
c.1576C>Tap.(Arg526Cys)P1(4)
c.3280_3281delap.(Lys1094Glufs*19)P1Novel
c.3336dupp.(Glu1113*)P1(21)
c.3551C>Tp.(Ala1184Val)P1(22)
c.3640C>Tp.(Arg1214Trp)P1(23)
c.4307G>Ap.(Arg1436Gln)P1(24, 25)
c.4406G>Tp.(Gly1469Val)P1(26)
c.4369G>Abp.(Ala1457Thr)P1(27)
c.4372C>Ap.(Gln1458Lys)P1Novel
c.4411G>Abp.(Asp1471Asn)P2(28, 29)
c.4451G>Ap.(Gly1484Glu)P1(30)
c.4516G>Ap.(Glu1506Lys)P14(10)
c.4547A>Cp.(Glu1516Ala)LP1Novel
c.4649T>Abp.(Val1550Asp)P1(27)
c.4651C>Gp.(Leu1551Val)P2(27)
KCNJ11NM_000525.3c.201G>Ccp.(Lys67Asn)P2(27)
c.539C>Tp.(Thr180Ile)P2Novel
C>T c-54 bases proximal of the translation initiation siteP1(27)
GLUD1NM_005271.4c.965G>Ap.(Arg322His)P4(31)
c.1493C>Tp.(Ser498Leu)P2(32)
GCKNM_033508.1c.193A>Gp.(Thr65Ala)P1Novel
c.638A>Gp.(Tyr213Cys)P1(33)
SLC16A1NM_003051.3c.-391_-390ins25bpp.?P2(34)
c.-202G>Ap.?P1(34)
HNF4ANM_000457.4c.992G>Ap.(Arg331His)P1(35)
GeneTranscriptAlleleProteinIn silico analysesCarriers (n)Ref.
ABCC8NM_000352.4c.560T>Ap.(Val187Asp)P24(9)
c.1576C>Tap.(Arg526Cys)P1(4)
c.3280_3281delap.(Lys1094Glufs*19)P1Novel
c.3336dupp.(Glu1113*)P1(21)
c.3551C>Tp.(Ala1184Val)P1(22)
c.3640C>Tp.(Arg1214Trp)P1(23)
c.4307G>Ap.(Arg1436Gln)P1(24, 25)
c.4406G>Tp.(Gly1469Val)P1(26)
c.4369G>Abp.(Ala1457Thr)P1(27)
c.4372C>Ap.(Gln1458Lys)P1Novel
c.4411G>Abp.(Asp1471Asn)P2(28, 29)
c.4451G>Ap.(Gly1484Glu)P1(30)
c.4516G>Ap.(Glu1506Lys)P14(10)
c.4547A>Cp.(Glu1516Ala)LP1Novel
c.4649T>Abp.(Val1550Asp)P1(27)
c.4651C>Gp.(Leu1551Val)P2(27)
KCNJ11NM_000525.3c.201G>Ccp.(Lys67Asn)P2(27)
c.539C>Tp.(Thr180Ile)P2Novel
C>T c-54 bases proximal of the translation initiation siteP1(27)
GLUD1NM_005271.4c.965G>Ap.(Arg322His)P4(31)
c.1493C>Tp.(Ser498Leu)P2(32)
GCKNM_033508.1c.193A>Gp.(Thr65Ala)P1Novel
c.638A>Gp.(Tyr213Cys)P1(33)
SLC16A1NM_003051.3c.-391_-390ins25bpp.?P2(34)
c.-202G>Ap.?P1(34)
HNF4ANM_000457.4c.992G>Ap.(Arg331His)P1(35)

Abbreviations: P, pathogenic; LP, likely pathogenic.

aThe variants are compound heterozygous.

bThe variant is compound heterozygous for the founder mutation ABCC8/c.560T>A, p.(Val187Asp).

cThe variants are compound heterozygous.

Table 2.

Pathogenic or likely pathogenic variants of the patients with congenital hyperinsulinism.

GeneTranscriptAlleleProteinIn silico analysesCarriers (n)Ref.
ABCC8NM_000352.4c.560T>Ap.(Val187Asp)P24(9)
c.1576C>Tap.(Arg526Cys)P1(4)
c.3280_3281delap.(Lys1094Glufs*19)P1Novel
c.3336dupp.(Glu1113*)P1(21)
c.3551C>Tp.(Ala1184Val)P1(22)
c.3640C>Tp.(Arg1214Trp)P1(23)
c.4307G>Ap.(Arg1436Gln)P1(24, 25)
c.4406G>Tp.(Gly1469Val)P1(26)
c.4369G>Abp.(Ala1457Thr)P1(27)
c.4372C>Ap.(Gln1458Lys)P1Novel
c.4411G>Abp.(Asp1471Asn)P2(28, 29)
c.4451G>Ap.(Gly1484Glu)P1(30)
c.4516G>Ap.(Glu1506Lys)P14(10)
c.4547A>Cp.(Glu1516Ala)LP1Novel
c.4649T>Abp.(Val1550Asp)P1(27)
c.4651C>Gp.(Leu1551Val)P2(27)
KCNJ11NM_000525.3c.201G>Ccp.(Lys67Asn)P2(27)
c.539C>Tp.(Thr180Ile)P2Novel
C>T c-54 bases proximal of the translation initiation siteP1(27)
GLUD1NM_005271.4c.965G>Ap.(Arg322His)P4(31)
c.1493C>Tp.(Ser498Leu)P2(32)
GCKNM_033508.1c.193A>Gp.(Thr65Ala)P1Novel
c.638A>Gp.(Tyr213Cys)P1(33)
SLC16A1NM_003051.3c.-391_-390ins25bpp.?P2(34)
c.-202G>Ap.?P1(34)
HNF4ANM_000457.4c.992G>Ap.(Arg331His)P1(35)
GeneTranscriptAlleleProteinIn silico analysesCarriers (n)Ref.
ABCC8NM_000352.4c.560T>Ap.(Val187Asp)P24(9)
c.1576C>Tap.(Arg526Cys)P1(4)
c.3280_3281delap.(Lys1094Glufs*19)P1Novel
c.3336dupp.(Glu1113*)P1(21)
c.3551C>Tp.(Ala1184Val)P1(22)
c.3640C>Tp.(Arg1214Trp)P1(23)
c.4307G>Ap.(Arg1436Gln)P1(24, 25)
c.4406G>Tp.(Gly1469Val)P1(26)
c.4369G>Abp.(Ala1457Thr)P1(27)
c.4372C>Ap.(Gln1458Lys)P1Novel
c.4411G>Abp.(Asp1471Asn)P2(28, 29)
c.4451G>Ap.(Gly1484Glu)P1(30)
c.4516G>Ap.(Glu1506Lys)P14(10)
c.4547A>Cp.(Glu1516Ala)LP1Novel
c.4649T>Abp.(Val1550Asp)P1(27)
c.4651C>Gp.(Leu1551Val)P2(27)
KCNJ11NM_000525.3c.201G>Ccp.(Lys67Asn)P2(27)
c.539C>Tp.(Thr180Ile)P2Novel
C>T c-54 bases proximal of the translation initiation siteP1(27)
GLUD1NM_005271.4c.965G>Ap.(Arg322His)P4(31)
c.1493C>Tp.(Ser498Leu)P2(32)
GCKNM_033508.1c.193A>Gp.(Thr65Ala)P1Novel
c.638A>Gp.(Tyr213Cys)P1(33)
SLC16A1NM_003051.3c.-391_-390ins25bpp.?P2(34)
c.-202G>Ap.?P1(34)
HNF4ANM_000457.4c.992G>Ap.(Arg331His)P1(35)

Abbreviations: P, pathogenic; LP, likely pathogenic.

aThe variants are compound heterozygous.

bThe variant is compound heterozygous for the founder mutation ABCC8/c.560T>A, p.(Val187Asp).

cThe variants are compound heterozygous.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close